{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:32:27Z","timestamp":1792618347724,"version":"4.5.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021121","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T20:51:46Z","timestamp":1309985506000},"page":"e21121","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers"],"prefix":"10.1371","volume":"6","author":[{"given":"Michael P.","family":"Stany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Vathipadiekal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Ozbun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bowtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Gout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Ellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Vivas-Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lopez-Berestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Birrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Mesonephroma ovarii.","volume":"35","author":"W Schiller","year":"1939","journal-title":"Am J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00433543","article-title":"Ultrastructure of clear cell carcinoma of the ovary. Case report and review of the literature.","volume":"385","author":"CY Genton","year":"1979","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0002-9378(73)90596-6","article-title":"Ultrastructure and histogenesis of clear cell carcinoma of the ovary.","volume":"115","author":"SG Silverberg","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0090-8258(89)90852-4","article-title":"Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma.","volume":"32","author":"EL Jenison","year":"1989","journal-title":"Gynecol Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0090-8258(89)90637-9","article-title":"Ovarian clear cell adenocarcinoma.","volume":"32","author":"AW Kennedy","year":"1989","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-8258(89)90043-7","article-title":"Clear cell carcinoma of the ovary: a study of 59 cases.","volume":"35","author":"MA Crozier","year":"1989","journal-title":"Gynecol Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in tumor type in low-stage versus high-stage ovarian carcinomas.","volume":"29","author":"M Kobel","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.","volume":"88","author":"T Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1634\/theoncologist.11-10-1089","article-title":"Treatment issues in clear cell carcinoma of the ovary: a different entity?","volume":"11","author":"D Pectasides","year":"2006","journal-title":"Oncologist"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2006.08.026","article-title":"Thromboembolic complications in patients with clear cell carcinoma of the ovary.","volume":"104","author":"Y Matsuura","year":"2007","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/j.1879-3479.1980.tb00251.x","article-title":"Clinicopathologic and histochemical study of ovarian clear cell carcinoma.","volume":"18","author":"I Nordback","year":"1980","journal-title":"Int J Gynaecol Obstet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/1097-0142(19800401)45:7<1615::AID-CNCR2820450717>3.0.CO;2-E","article-title":"Ultrastructure of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women.","volume":"45","author":"GR Dickersin","year":"1980","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","article-title":"Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.","volume":"11","author":"KK Zorn","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref14","first-page":"4722","article-title":"Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.","volume":"62","author":"DR Schwartz","year":"2002","journal-title":"Cancer Res"},{"key":"ref15","first-page":"4811","article-title":"Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.","volume":"9","author":"KK Zorn","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.","volume":"65","author":"T Bonome","year":"2005","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1038\/sj.onc.1207959","article-title":"Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.","volume":"23","author":"H Donninger","year":"2004","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-07-5771","article-title":"Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR\/Src\/FAK\/paxillin in ovarian cancer.","volume":"68","author":"M Aponte","year":"2008","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.","volume":"65","author":"CN Landen Jr","year":"2005","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1158\/1078-0432.CCR-06-0021","article-title":"Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.","volume":"12","author":"J Halder","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1158\/0008-5472.CAN-07-0858","article-title":"Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.","volume":"67","author":"CN Landen Jr","year":"2007","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"17069","DOI":"10.1073\/pnas.0708148104","article-title":"Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.","volume":"104","author":"JM Ebos","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/jm0204183","article-title":"Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase.","volume":"46","author":"L Sun","year":"2003","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2004.09.025","article-title":"Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.","volume":"96","author":"CH Lee","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2008.03.011","article-title":"Xenografts of primary human gynecological tumors grown under the renal capsule of NOD\/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.","volume":"110","author":"JZ Press","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref26","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship.","volume":"9","author":"DB Mendel","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.","volume":"271","author":"GL Semenza","year":"1996","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.onc.1210008","article-title":"Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance.","volume":"26","author":"M Kilic","year":"2007","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","article-title":"Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.","volume":"93","author":"BD Kelly","year":"2003","journal-title":"Circ Res"},{"key":"ref30","first-page":"1807","article-title":"Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.","volume":"3","author":"MS Tsao","year":"1997","journal-title":"Clin Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"R1085","DOI":"10.1152\/ajpregu.00794.2005","article-title":"Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.","volume":"291","author":"O Nevo","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1538-7836.2006.02193.x","article-title":"Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome.","volume":"4","author":"MJ Cuadrado","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.CIR.92.2.238","article-title":"Copper-induced tissue factor expression in human monocytic THP-1 cells and its inhibition by antioxidants.","volume":"92","author":"DJ Crutchley","year":"1995","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1158\/0008-5472.CAN-05-4281","article-title":"Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells.","volume":"66","author":"Z Wang","year":"2006","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ni1234","article-title":"Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism.","volume":"6","author":"M Ciofani","year":"2005","journal-title":"Nat Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/beta-catenin and PI3K\/Pten signaling pathways.","volume":"11","author":"R Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/onc.2009.470","article-title":"Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.","volume":"29","author":"K Yamaguchi","year":"2010","journal-title":"Oncogene"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccr.2009.10.018","article-title":"A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.","volume":"16","author":"SC Mok","year":"2009","journal-title":"Cancer Cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1073\/pnas.91.8.3353","article-title":"Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.","volume":"91","author":"CA Sprecher","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","first-page":"74","article-title":"Coagulation in the pathophysiology of hemolytic anemias.","author":"MD Cappellini","year":"2007"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1160\/TH07-01-0071","article-title":"Polymorphisms in the endothelial protein C receptor gene and thrombophilia.","volume":"98","author":"P Medina","year":"2007","journal-title":"Thromb Haemost"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1210\/en.2004-0213","article-title":"Crucial role of activin a in tubulogenesis of endothelial cells induced by vascular endothelial growth factor.","volume":"145","author":"K Maeshima","year":"2004","journal-title":"Endocrinology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","article-title":"Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy.","volume":"165","author":"V Poulaki","year":"2004","journal-title":"Am J Pathol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1158\/0008-5472.CAN-04-3877","article-title":"The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation.","volume":"65","author":"S Frede","year":"2005","journal-title":"Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0898-6568(01)00209-1","article-title":"Signal transduction by VEGF receptor-1 wild type and mutant proteins.","volume":"13","author":"N Ito","year":"2001","journal-title":"Cell Signal"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2006-0920","article-title":"Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.","volume":"91","author":"PJ Pollard","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"29936","DOI":"10.1074\/jbc.M204733200","article-title":"Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.","volume":"277","author":"JS Isaacs","year":"2002","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2004.11.020","article-title":"Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression.","volume":"42","author":"GY Gwak","year":"2005","journal-title":"J Hepatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1535-7163.233.3.3","article-title":"Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.","volume":"3","author":"S Welsh","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9440(10)63924-7","article-title":"Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.","volume":"162","author":"J Chen","year":"2003","journal-title":"Am J Pathol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2310\/6650.2001.34040","article-title":"Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase.","volume":"49","author":"VM Gitlits","year":"2001","journal-title":"J Investig Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0896-8411(95)80027-1","article-title":"Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis.","volume":"8","author":"M Walter","year":"1995","journal-title":"J Autoimmun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2353\/ajpath.2007.060477","article-title":"Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1alpha.","volume":"170","author":"MH Wu","year":"2007","journal-title":"Am J Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:05:01Z","timestamp":1686186301000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021121"}},"subtitle":[],"editor":[{"given":"Chad","family":"Creighton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021121","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}